Natural supplement for improving cognitive function and eye health
Aronia, Cognition, and Eye Health
This study tests if taking aronia melanocarpa extract can help young adults improve their memory and focus, especially during stressful times like online learning and work.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht) |
| Trial ID | NCT05683002 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of aronia melanocarpa extract supplementation on cognitive performance and eye health in healthy young adults aged 18-35. It aims to address the negative impacts of online education and workplace stress on concentration and productivity. Participants will undergo a randomized, double-blind, placebo-controlled, cross-over design over a period of six weeks to assess the long-term effects of the supplement on memory and attention. The study also includes a cellulose supplementation as a control.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy men and women aged 18-35 with a BMI between 18-30 kg/m2.
Not a fit: Patients with severe medical conditions or those who smoke may not receive any benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a natural method to enhance cognitive performance and eye health for individuals working or studying online.
How similar studies have performed: Previous studies have shown short-term benefits of anthocyanin supplementation on cognitive performance, but this study explores a novel long-term approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy men and women, aged between 18-35 years * BMI between 18-30 kg/m2 * Systolic blood pressure \< 160 mmHg and diastolic blood pressure \< 100 mmHg * Stable body weight (weight gain or loss \< 3 kg in the past three months) * Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study * No difficult venipuncture as evidenced during the screening visit Exclusion Criteria: * Smoking or smoking cessation \< 12 months * Contact lens wearers * Past refractive surgery * Severe medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), kidney failure, auto-inflammatory diseases, rheumatoid arthritis, diabetes mellitus, cardiovascular disease * Use of dietary supplements or medication affecting the main outcomes of the study * Use of an investigational product within another biomedical intervention trial within the previous month * Familial hypercholesterolemia * Abuse of drugs * More than 3 alcoholic consumptions per day
Where this trial is running
Maastricht
- Maastricht University — Maastricht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Jogchum Plat, Prof — Maastricht University
- Study coordinator: Sanne Ahles, Msc
- Email: s.ahles@maastrichtuniversity.nl
- Phone: +31437114555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.